The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 7 years. This subset of the different portfolios I regularly analyze has now exceeded 260 weeks of public selections as part of this ongoing live forward-testing research. The frequency of 10%+ returns in a week is averaging over 4x the broad market averages in the past 5+ years.
In 2017, the sample size began with 12 stocks, then 8 stocks in 2018, and at members' request since 2020, I now generate only 4 selections each week. In addition 2 Dow 30 picks are provided, as well as a new active ETF portfolio that competes against a signal ETF model. Monthly Growth & Dividend MDA breakout stocks continue to beat the market each year as well. I offer 11 top models of short and long term value and momentum portfolios that have beaten the S&P 500 since my trading S&P 500 since my trading studies were made public.
The Momentum Gauges®, economic events, and weekly market outlook are now separated into a new weekly article here which also includes my new weekly Technical Market update videos:
Momentum Gauge® stoplight signals
In a quick study of the MDA breakout selections YTD there are 79 picks in 32 weeks beating the S&P 500. 51 picks beating the S&P 500 by over 10%+ in double digits. Leading MDA gainers include (CLFD) +90.96%, (ME) +84.8%, (TDW) +75.15, (RES) +71.9% of the 79 picks beating the major indices YTD.
Additional background, measurements, and high frequency breakout records on the Weekly MDA Breakout model is here: Value And Momentum MDA Breakouts +70.5% In 52 Weeks: Final 2021 Year End Report Card
Momentum Gauge® trading signal: Positive conditions ahead of Week 33
First half returns with all weekly returns on the V&M Dashboard
Red weekly color indicates negative Market Momentum Gauge signals. MDA breakout selections outperform when the market signal is positive and daily negative values are below 40 level.
Historical MDA Breakout minimal buy/hold returns are at +70.5% YTD when trading only in the positive weeks consistent with the positive Momentum Gauges® signals. Remarkably, the frequency streak of 10% gainers within a 4- or 5-day trading week continues at highly statistically significant levels above 80% not counting frequent multiple 10%+ gainers in a single week.
Longer term many of these selections join the V&M Multibagger list now at 129 weekly picks with over 100%+ gains, 62 picks over 200%+, 21 picks over 500%+ and 14 picks with over 1000%+ gains since January 2019 such as:
More than 200 stocks have gained over 10% in a 5-day trading week since this MDA testing began in 2017. A frequency comparison chart is at the end of this article. Readers are cautioned that these are highly volatile stocks that may not be appropriate for achieving your long term investment goals: How to Achieve Optimal Asset Allocation
The picks for next week consist of 1 Financial, 1 Technology, 2 Healthcare sector stocks. These stocks are released to members in advance every Friday morning near the open for the best gains. Prior selections may be doing well, but for research purposes I deliberately do not duplicate selections from the prior week. These selections are based on MDA characteristics from my research, including strong money flows, positive sentiment, and strong fundamentals -- but readers are cautioned to follow the Momentum Gauges® for the best results.
Beam Therapeutics - Healthcare / Medical Care Facilities
Price Target: $90.00/share (See my FAQ #20 on price targets)
|Aug-11-22 10:01AM||ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox GlobeNewswire|
|Aug-09-22 07:45AM||Beam Therapeutics Inc. Reports Q2 Loss, Tops Revenue Estimates Zacks|
|Aug-09-22 07:27AM||Even after rising 8.2% this past week, Beam Therapeutics shareholders are still down 40% over the past year Simply Wall St.|
|Aug-09-22 06:30AM||Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results GlobeNewswire|
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia.
(Source: Company Resources)
Everspin Technologies - Technology / Semiconductors
Price Target: $11.00/share (See my FAQ #20 on price targets)
|Aug-11-22 04:00PM||Everspin Reports Unaudited Second Quarter 2022 Financial Results Business Wire|
|Aug-01-22 11:34PM||Everspin Announces New STT-MRAM EM128LX xSPI Memory. Business Wire|
|Jul-27-22 10:13PM||Everspin to Host Second Quarter 2022 Earnings Call on August 11th, 2022 Business Wire|
|Jul-17-22 09:16AM||Are Institutions Heavily Invested In Everspin Technologies, Inc.'s Shares? Simply Wall St.|
|Jun-17-22 04:49PM||Embedded World Fair: Menta and Everspin Technologies will demonstrate an innovative collaboration with MRAM and eFPGA Business Wire|
Everspin Technologies, Inc. manufactures and sells magnetoresistive random access memory (MRAM) products in the United States, Hong Kong, Japan, China, Canada, and internationally. It offers Toggle MRAM, spin-transfer torque MRAM, and tunnel magneto resistance sensor products, as well as foundry services for embedded MRAM.
(Source: Company Resources)
First, be sure to follow the Momentum Gauges® when applying the same MDA breakout model parameters to only 30 stocks on the Dow Index. Conditions have delivered the worst first half to the stock market since 1970. Second, these selections are made without regard to market cap or the below-average volatility typical of mega-cap stocks that may produce good results relative to other Dow 30 stocks.
The most recent picks of weekly Dow selections in pairs for the last 5 weeks:
|Symbol||Company||Current % return from selection Week|
|(UNH)||UnitedHealth Group||+4.61% Reported Q2 - July 15th|
|(AXP)||American Express||+18.29% Reported Q2 - July 22nd|
|(TRV)||The Travelers Companies||+0.85% Reported Q2 - July 21|
If you are looking for a much broader selection of large cap breakout stocks beyond the weekly stocks, I recommend these long term portfolios. The new mid-year selections were released to members to start July:
These long term selections are significantly outperforming many major Hedge Funds and all the hedge fund averages since inception. Consider the actively managed ARK Innovation fund down -45.0% YTD, Tiger Global Management -52% YTD, RTW Investment Group -34% YTD.
Merck & Co. (MRK)
Merck is in strong breakout conditions following earnings results July 28th moving higher in the positive channel. Institutions are net buyers and insiders are net selling as sentiment improves sharply with high net MFI inflows. Breakout conditions to prior highs remains strong and analysts have consensus target around $100/share with recent upgrades to $102/share.
As I have documented before from my research over the years, these MDA breakout picks were designed as high frequency gainers.
These documented high frequency gains in less than a week continue into 2020 at rates more than four times higher than the average stock market returns against comparable stocks with a minimum $2/share and $100 million market cap. The enhanced gains from further MDA research in 2020 are both larger and more frequent than in previous years in every category. ~ The 2020 MDA Breakout Report Card
The frequency percentages remain very similar to returns documented here on Seeking Alpha since 2017 and at rates that greatly exceed the gains of market returns by 2x and as much as 5x in the case of 5% gains.
The 2021 and 2020 breakout percentages with 4 stocks selected each week.
MDA selections are restricted to stocks above $2/share, $100M market cap, and greater than 100k avg daily volume. Penny stocks well below these minimum levels have been shown to benefit greatly from the model but introduce much more risk and may be distorted by inflows from readers selecting the same micro-cap stocks.
These stocks continue the live forward-testing of the breakout selection algorithms from my doctoral research with continuous enhancements over prior years. These Weekly Breakout picks consist of the shortest duration picks of seven quantitative models I publish from top financial research that also include one-year buy/hold value stocks. Remember to follow the Momentum Gauges® in your investing decisions for the best results.
All the V&M portfolio models are beating the market indices through the worst 6 month start since 1970. New mid-year value portfolios are up sharply to start the next long term buy-hold measurement period.
The final 2021 returns for the different portfolio models from January of last year are shown below.
All the very best to you, stay safe and healthy and have a great week of trading!
JD Henning, PhD, MBA, CFE, CAMS
If you are looking for a great community to apply proven financial models with picks ranging from short term breakouts to long term value and forensic selections, join our 1,200+ outstanding members at Value & Momentum Breakouts
See what members are saying now - Click HERE
This article was written by
Welcome! I am a Finance PhD, MBA, investment adviser, fraud examiner and certified anti-money laundering specialist with more than 30 years trading and investing stocks and other securities. I'm the founder of Value & Momentum Breakouts.
I'm JD Henning, the founder of Value & Momentum Breakouts. I've spent decades studying how to get better returns in the market. I've earned degrees researching markets, and even more importantly, I've spent the time myself as a trader and investor. I am one of those unusual multi-millionaire, PhD's in finance, former Coast Guard officer with a bunch of certifications ranging from anti-money laundering specialist, investment adviser, to fraud examiner... who genuinely enjoys helping others do well in the markets. I'm bringing the fruits of my experience and research to this service. I am highly accessible to members to answer questions and give guidance.
It's been quite the start of the year for investors. My guess is, after a decade of good times in the market, you’re here looking for some guidance in how to navigate these volatile markets and the uncertainty of the coronavirus and inflationary conditions. You’re in the right place. For the past 5 years I’ve made my trading systems public and helped hundreds of my subscribers navigate and profit from every market downturn and breakout - including the coronavirus crash last year.
Value & Momentum Breakouts doesn't stop with the Momentum Gauges® and the Bull/Bear ETF strategy. The service is designed for investors who appreciate having easy access to quick picks from many top quantitative financial models across different types of investing strategies. Portfolios and selections cover all types of investments:
Commodity and Volatility fund trading
Cryptocurrency chart analysis
Long term high-dividend growth stocks
Short term high-frequency breakout stocks
Forensic analysis value stocks
Value enhanced long term growth picks
ETF sector and bull/bear combination trades
Dow mega cap breakout picks
Sector and Index Momentum Gauges® for market timing
I share my expertise by generating frequent Value & Momentum Breakout stock portfolios from the different financial algorithms across peer-reviewed financial literature. The best selection of stocks from these algorithms are applied to the Premium Portfolio, beating the S&P 500 for the 3rd straight year in a row with average annual gains of 32.98% through 2020.
Try a 2-Week FREE trial and see all the value for yourself.
Disclosure: I/we have a beneficial long position in the shares of FNGU, BULZ, KOLD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Additional disclosure: I continue to follow the Market Momentum Gauge® and Sector Momentum Gauge® signals. I adjust my exposure ahead of weekends and holidays to minimize the risk from these high volatility 3x funds that may not be appropriate investments for your portfolio. Readers are highly encouraged to consider your own optimal asset allocation strategies to diversify risks and enhance returns. I have been mostly in cash this year with many weeks of negative Momentum Gauge signals.